Industrial Alliance Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Industrial Alliance Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,040	Closed	-$3.11M	–	528
2022 Q4	$3.11M	Sell	30,040 -17,020	-36%	-$1.6M	0.09%	191
2022 Q3	$3.99M	Buy	47,060 +2,030	+5%	+$181K	0.12%	160
2022 Q2	$3.73M	Sell	45,030 -5,450	-11%	-$434K	0.11%	167
2022 Q1	$3.9M	Buy	+50,480	New	+$4.22M	0.09%	181

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Industrial Alliance Investment Management's BMRN Position: Q1 2023 in Review

Industrial Alliance Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2023, closing a stake of 30,040 shares — an estimated $3.11M sold.

Industrial Alliance Investment Management first reported a position in BMRN in Q1 2022 and held it in 4 quarters. The position peaked at $3.99M in Q3 2022. 553 funds tracked by Wall St. Rank hold BMRN as of Q1 2023.

Industrial Alliance Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Industrial Alliance Investment Management sold 30,040 BioMarin Pharmaceuticals shares in Q1 2023, an estimated $3.11M.
Industrial Alliance Investment Management first reported a position in BioMarin Pharmaceuticals in Q1 2022 and held it in 4 quarters.
Industrial Alliance Investment Management's BioMarin Pharmaceuticals position peaked at $3.99M in Q3 2022.
553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q1 2023, filed 11 May 2023.